Life sciences company Bio-Techne (NASDAQ:TECH) reported Q4 CY2025 results beating Wall Street’s revenue expectations, but sales were flat year on year at $295.9 million. Its non-GAAP profit of $0.46 ...
Issued on behalf of VisionWave Holdings, Inc. NEW YORK, Feb. 5, 2026 /CNW/ — Equity Insider News Commentary – Defense is no longer about physical walls; it is about the digital shield that ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果